Evidence map›Paper›PMID 24810406›Full record

ArticlePLoS genetics2014

RPM-1 uses both ubiquitin ligase and phosphatase-based mechanisms to regulate DLK-1 during neuronal development.

Scott T Baker, Karla J Opperman, Erik D Tulgren, Shane M Turgeon, Willy Bienvenut, Brock Grill

Open access · goldAbstract read
In one paragraph

Article in PLoS genetics, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
2.9field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 46 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. JNK Cascade-Induced Apoptosis-A Unique Role in GqPCR Signaling.International journal of molecular sciences · 2023
    Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Scott T BakerDepartment of Neuroscience, The Scripps Research Institute, Jupiter, Florida, United States of America; Department of Pharmacology, University of Minnesota, Minneapolis, Minnesota, United States of America.
Karla J OppermanDepartment of Neuroscience, The Scripps Research Institute, Jupiter, Florida, United States of America.
Erik D TulgrenDepartment of Pharmacology, University of Minnesota, Minneapolis, Minnesota, United States of America.
Shane M TurgeonDepartment of Neuroscience, The Scripps Research Institute, Jupiter, Florida, United States of America.
Willy BienvenutCNRS, Campus de Recherche de Gif, Gif-sur-Yvette, France.
Brock GrillDepartment of Neuroscience, The Scripps Research Institute, Jupiter, Florida, United States of America.
Scripps Research Institute · USCentre National de la Recherche Scientifique · FRUniversity of Minnesota · US

Funding

Mechanisms of synapse formation and axon termination in C. elegansR01NS072129 · NINDS · UNIVERSITY OF MINNESOTA · PI GRILL, BROCK · 2011 to 2024
$8.0M
NINDS NIH HHS R01 NS072129
6 · The paper itself

Abstract

The Pam/Highwire/RPM-1 (PHR) proteins are key regulators of neuronal development that function in axon extension and guidance, termination of axon outgrowth, and synapse formation. Outside of development, the PHR proteins also regulate axon regeneration and Wallerian degeneration. The PHR proteins function in part by acting as ubiquitin ligases that degrade the Dual Leucine zipper-bearing Kinase (DLK). Here, we show that the Caenorhabditis elegans PHR protein, Regulator of Presynaptic Morphology 1 (RPM-1), also utilizes a phosphatase-based mechanism to regulate DLK-1. Using mass spectrometry, we identified Protein Phosphatase Magnesium/Manganese dependent 2 (PPM-2) as a novel RPM-1 binding protein. Genetic, transgenic, and biochemical studies indicated that PPM-2 functions coordinately with the ubiquitin ligase activity of RPM-1 and the F-box protein FSN-1 to negatively regulate DLK-1. PPM-2 acts on S874 of DLK-1, a residue implicated in regulation of DLK-1 binding to a short, inhibitory isoform of DLK-1 (DLK-1S). Our study demonstrates that PHR proteins function through both phosphatase and ubiquitin ligase mechanisms to inhibit DLK. Thus, PHR proteins are potentially more accurate and sensitive regulators of DLK than originally thought. Our results also highlight an important and expanding role for the PP2C phosphatase family in neuronal development.

Indexed as

NeurogenesisAnimalsAxonsCaenorhabditis elegans ProteinsGuanine Nucleotide Exchange FactorsMAP Kinase Kinase KinasesMyristic AcidPhosphoric Monoester HydrolasesProtein BindingUbiquitin-Protein LigasesCaenorhabditis elegans ProteinsDLK-1 protein, C elegansGuanine Nucleotide Exchange FactorsMAP Kinase Kinase KinasesMyristic AcidPhosphoric Monoester HydrolasesRPM-1 protein, C elegansUbiquitin-Protein Ligases

Identifiers

PMID24810406
PMCPMC4014440
OpenAlexW2084037119

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.